Love hormone nasal spray tested for borderline personality disorder

NCT ID NCT02225600

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 31 times

Summary

This pilot study tested whether a nasal spray containing oxytocin, sometimes called the 'love hormone,' could improve trust and cooperation in people with borderline personality disorder (BPD). Forty participants (some with BPD, some healthy) played a trust game after receiving either oxytocin or a placebo. The study aimed to see if oxytocin could normalize brain activity and behavior during the game. However, the study was suspended, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Oxytocin (nasal spray)

What this could lead to

If it works, this could point toward a way to help people with borderline personality disorder feel more trusting and cooperative in social situations.

What could go wrong

This is a very small pilot study that has been suspended. It only looks at short-term effects in a lab setting, so results may not apply to real life or lead to a treatment.

Conditions

The condition(s) this trial relates to.

borderline personality disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.